Skip to main content
. Author manuscript; available in PMC: 2022 Sep 1.
Published in final edited form as: Dig Dis Sci. 2020 Sep 7;66(9):3186–3191. doi: 10.1007/s10620-020-06588-6

Fig. 1.

Fig. 1

NAFLD inclusion criteria for IBD population. Nonalcoholic fatty liver disease (NAFLD), inflammatory bowel disease (IBD), hepatitis c virus (HCV), hepatitis b virus (HBV), human immunodeficiency virus (HIV), alcohol (EtOH), methotrexate (MTX), primary sclerosing cholangitis (PSC)